MedTrace Logo

Clinical Trial on Rapid Immune Modulating Effects

NCT07206407 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2025-12-17

No results posted yet for this study

Summary

The goal for this clinical trial is to document rapid effects of a nutritional blend on immune cells. A double-blind, placebo-controlled, cross-over study design will be used.

Conditions

  • Immune Surveillance

Interventions

DIETARY_SUPPLEMENT

Placebo

Four capsules.

DIETARY_SUPPLEMENT

Nutraceutical blend

Four capsules.

Sponsors & Collaborators

  • Natural Immune Systems Inc

    lead OTHER

Principal Investigators

  • Gitte S. Jensen, PhD · NIS Labs

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-28
Primary Completion
2026-02-01
Completion
2026-03-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07206407 on ClinicalTrials.gov